MSWA
BIIB icon

Marshall & Sterling Wealth Advisors’s Biogen BIIB Stock Holding History

Marshall & Sterling Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49
Closed -$6.86K – 372
2025
Q3 		$6.86K Hold
49
– – ﹤0.01% 437
2025
Q2 		$6.15K Buy
49
+1
+2% +$125 ﹤0.01% 450
2025
Q1 		$6.57K Buy
+48
New +$6.86K ﹤0.01% 417

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall & Sterling Wealth Advisors's BIIB Position: Q4 2025 in Review

Marshall & Sterling Wealth Advisors sold out of Biogen (BIIB) in Q4 2025, closing a stake of 49 shares — an estimated $6.86K sold.

Marshall & Sterling Wealth Advisors first reported a position in BIIB in Q1 2025 and held it in 3 quarters. The position peaked at $6.86K in Q3 2025. 1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Marshall & Sterling Wealth Advisors reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Marshall & Sterling Wealth Advisors sold 49 Biogen shares in Q4 2025, an estimated $6.86K.
  • Marshall & Sterling Wealth Advisors first reported a position in Biogen in Q1 2025 and held it in 3 quarters.
  • Marshall & Sterling Wealth Advisors's Biogen position peaked at $6.86K in Q3 2025.
  • 1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.